SCFβ-TrCP1 Controls Smad4 Protein Stability in Pancreatic Cancer Cells

Abstract

Smad4, also known as deleted in pancreatic carcinoma locus 4 (DPC4), is a critical co-factor in signal transduction pathways activated by transforming growth factor (TGF)-beta-related ligands that regulate cell growth and differentiation. Mutations in Smad4/DPC4 have been identified in approximately 50% of pancreatic adenocarcinomas. Here we report that SCF(beta-TrCP1), a ubiquitin (E3) ligase, is a critical determinant for Smad4 protein degradation in pancreatic cancer cells. We found that F-box protein beta-TrCP1 in this E3 ligase interacted with Smad4 and that SCF(beta-TrCP1) inhibited TGF-beta biological activity in pancreatic cancer cells by decreasing Smad4 stability. Very low Smad4 protein levels in human pancreatic ductal adenocarcinoma cells were observed by immunohistochemistry. By analyzing pancreatic tumor-derived Smad4 mutants, we found that most point-mutated Smad4 proteins, except those within or very close to a mutation cluster region, exhibited higher interaction affinity with beta-TrCP1 and significantly elevated protein ubiquitination by SCF(beta-TrCP1). Furthermore, AsPC-1 and Caco-2, two cancer cell lines harboring Smad4 point mutations, exhibited rapid Smad4 protein degradation due to the effect of SCF(beta-TrCP1). Both Smad4 levels and TGF-beta signaling were elevated by retrovirus-delivered beta-TrCP1 siRNA in pancreatic cancer cells. Therefore, inhibition of Smad4-specific E3 ligase might be a target for therapeutic intervention in pancreatic cancer.

Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas

“…β-TrCP1 is essential for many aspects of tumorigenesis [62,63]. β-TrCP1 interacts with HIV-1 Vpu and regulates HIV release by mediating the degradation of its substrates.…”

The Emerging Role of the COP9 Signalosome in Cancer

“…A few interesting associations that could become altered via altered CSN function are the cyclin-dependent kinase inhibitors p27 (35,43), p57 (18), and p21 (14) and their transcriptional regulators (i.e., SMAD4 and SMAD7; refs. [44][45][46][47] as well as several cyclins (cyclin D1, cyclin E, and cyclin B1; refs. 17,20,24,28).…”

RNF13: a novel RING-type ubiquitin ligase over-expressed in pancreatic cancer

“…Breast cancer-associated gene 2 (BCA2) is an E3 with a RING domain that is over-expressed in invasive breast cancer and positively correlates with estrogen receptor expression and survival, but negatively with lymph node metastasis [4]. Recently ubiquitin ligase SCF-β-TrCP1 has been shown to be a critical determinant for Smad4 protein degradation in pancreatic cancer cells, and the somatic homozygous H460R mutation in FBXW7, a subunit of an SCF-type ubiquitin ligase complex associated with Cyclin E over-expression, was observed in a subset of pancreatic cancers [5,6]. A hallmark of pancreatic cancer is its extensive local invasion and early systemic dissemination.…”